Sumitomo Seika Chemicals Company,Limited. (4008) FY2026 Q3

Quick View

Executive Summary

The defining feature of the results was earnings growth without revenue growth: Operating Income increased by double digits despite a decline in Revenue, while Net Income fell substantially due to extraordinary losses. Revenue was ¥111.67B (-0.9% YoY), Operating Income was ¥10.31B (+18.7%), Ordinary Income was ¥10.49B (+9.3%), and Net Income was ¥4.98B (-27.8%). Although improved Operating Income margins resulting from cost-of-sales and SG&A expense controls indicate enhanced core earnings power, the recognition of ¥3.49B in extraordinary losses, including an impairment loss at the Chiba Plant, reduced bottom-line profit.

Factors Affecting Results

【Revenue】Revenue was ¥111.67B, down 0.9% YoY. Superabsorbent polymers, the main business (external Revenue: ¥8.74B, composition ratio: 78.3%), declined 0.7%, while Functional Materials (external Revenue: ¥2.40B, composition ratio: 21.5%) declined 1.5%; both segments reported lower Revenue.

【Profit and Loss】Operating Income was ¥10.31B (+18.7% YoY), and the Operating Income margin improved to 9.2% from approximately 7.7% in the same period of the previous year. Segment profit for Superabsorbent Polymers was ¥8.25B (+28.3%), with the segment margin improving by approximately 213bp to 9.4%, driving the increase in Company-wide profit. In contrast, Functional Materials recorded segment profit of ¥2.04B (-7.4%), with its margin declining by approximately 54bp to 8.5%, producing a contrasting trend. Although Ordinary Income increased 9.3% to ¥10.49B, the Company recorded extraordinary income of ¥0.92B, including ¥0.82B in gains on sales of investment securities, against extraordinary losses of ¥3.49B, including ¥0.22B in impairment losses. Consequently, Net Income declined substantially to ¥4.98B (-27.8%). The result was an increase in profit at the operating level despite lower Revenue, while Net Income declined due to extraordinary losses.

Segment Analysis

Superabsorbent Polymers recorded Revenue of ¥8.74B (-0.7% YoY), segment profit of ¥8.25B (+28.3%), and a segment margin of 9.4% (7.3% in the previous year), demonstrating a marked improvement in profitability. Functional Materials recorded Revenue of ¥2.40B (-1.5%), segment profit of ¥2.04B (-7.4%), and a margin of 8.5% (approximately 9.0% in the previous year), indicating deterioration. An impairment loss of ¥0.22B was recognized for polyethylene powder manufacturing equipment at the Chiba Plant. The Company-wide improvement in profit is dependent on Superabsorbent Polymers, while deteriorating profitability in Functional Materials remains a challenge going forward.

Key Financial Indicators

【Profitability】The 9.2% Operating Income margin improved from approximately 7.7% in the same period of the previous year, indicating operating leverage under a cost structure comprising a gross margin of 23.1% and an SG&A expense ratio of 13.9%. The Net Income margin was 4.5%, below the operating-level margin, due to extraordinary losses and an effective tax rate of 37.1%.

【Cash Flow Quality】Accounts receivable of ¥36.31B represented 24.1% of total assets, with DSO at approximately 89 days on an annualized basis. DIO for inventories of ¥20.16B was approximately 64 days on an annualized basis. Both exceeded 60 days, suggesting working capital is tied up. Construction in progress of ¥23.69B accounted for 42.5% of property, plant and equipment, indicating that large-scale investments are underway.

【Investment Efficiency】ROE of 5.0% is relatively low because it is calculated against a substantial equity base, reflected in an Equity Ratio of 66.4%. ROE decomposes into a Net Income margin of 4.5% × total asset turnover of 0.74x × financial leverage of 1.51x.

【Financial Soundness】With an Equity Ratio of 66.4%, a current ratio of 225.5%, and cash and deposits of ¥19.55B, the Company maintains a conservative financial foundation. D/E was low at 0.18x against interest-bearing debt of ¥18.07B, while interest coverage also remained high.

Cash Flow Analysis

Although the Company does not disclose a statement of cash flows, fund movements can be inferred from changes in the balance sheet. Cash and deposits increased to ¥19.55B from ¥16.86B in the previous year. Meanwhile, accounts receivable increased from ¥36.31B to the ¥36.31B range in the previous year, while construction in progress expanded to ¥23.69B from ¥20.06B, suggesting that investing activities and increased working capital are raising funding needs. Long-term borrowings increased to ¥10.90B from ¥5.00B in the previous year, indicating that funding for large-scale capital expenditures is being raised through long-term borrowings. Short-term borrowings declined to ¥7.17B from ¥13.33B in the previous year, suggesting a shift in the funding structure from short-term to long-term financing. Overall, the Company appears to be allocating internally generated funds from higher Operating Income and long-term borrowings toward expanding investment and working capital.

Earnings Quality

The increase in Operating Income to ¥10.31B strongly reflects an improvement in core earnings power and is largely recurring in nature, while the conversion to Net Income of ¥4.98B was significantly affected by non-recurring items. Of the ¥0.92B in extraordinary income, ¥0.82B in gains on sales of investment securities was non-recurring and should be excluded when assessing recurring earnings power. Extraordinary losses of ¥3.49B included a ¥0.22B impairment loss on equipment at the Chiba Plant, suggesting profitability issues in part of the business structure. Non-operating income and expenses were positive due to interest received and other items, and the difference between Ordinary Income of ¥10.49B and Operating Income of ¥10.31B was modest. The effective tax rate was somewhat high at 37.1%, suppressing the conversion of Profit Before Tax of ¥7.92B into Net Income of ¥4.98B. Comprehensive Income was ¥8.58B, exceeding Net Income by ¥3.59B, primarily due to an increase in foreign currency translation adjustments. Accordingly, the Company’s underlying earning power is reasonably assessed as being closer to Operating Income than to Net Income for the period.

Earnings Forecast and Guidance

Progress against the full-year Company forecast was 75.5% for Revenue, 68.7% for Operating Income, 70.0% for Ordinary Income, and 71.2% for Net Income. Revenue was in line with the standard Q3 progress rate of 75%, while profit progress was slightly below this level. To achieve the full-year Operating Income forecast of ¥15.00B (+40.0% YoY), approximately ¥4.69B in Operating Income, equivalent to an Operating Income margin of approximately 12.9%, will be required in Q4. This would exceed the 9.2% margin for the cumulative Q3 period. The Revenue forecast is ¥148.00B (+0.3% YoY), which is expected to remain broadly flat; continued profitability improvement will therefore be the key to achieving earnings growth.

Shareholder Returns

The Q2 dividend was ¥100.00 per share, and the full-year dividend forecast is ¥220.00 (assuming a year-end dividend of ¥120.00). Based on the full-year Net Income forecast of ¥7.00B and the number of shares outstanding, the full-year total dividend is calculated at approximately ¥3.08B, resulting in a Payout Ratio of approximately 44.0%. This is below the 60% level generally regarded as a guideline for the sustainability of shareholder returns, indicating that a balance with retained earnings is maintained. The Company holds 945,935 treasury shares; however, no additional repurchases during the period were confirmed, and shareholder returns are assessed as being limited to dividends.

Risk Factors

1. Segment profitability disparity: While the mainstay Superabsorbent Polymers segment improved its margin to 9.4% (approximately +213bp YoY), the Functional Materials segment margin declined to 8.5% (approximately -54bp YoY). Company-wide profit improvement depends on Superabsorbent Polymers, and continued deterioration in Functional Materials profitability could limit the scope for further improvement in the Company-wide margin.

2. Working capital efficiency: Accounts receivable of ¥36.31B (DSO: approximately 89 days) and inventories of ¥20.16B (DIO: approximately 64 days) both exceeded 60 days, and prolonged collection and inventory holding periods could result in working capital becoming tied up. Construction in progress of ¥23.69B accounted for 42.5% of property, plant and equipment, making the progress of large-scale investments and their contribution to earnings after commencement of operations key monitoring points.

3. Bottom-line volatility from extraordinary gains and losses: Extraordinary losses of ¥3.49B, including a ¥0.22B impairment loss on Chiba Plant equipment, exceeded extraordinary income of ¥0.92B, resulting in a net loss of ¥2.57B. The fact that improved Operating Income has not translated directly into higher Net Income warrants attention when assessing earnings quality.

Industry Benchmark (For Reference; Compiled by the Company)

Profitability and Returns

The Operating Income margin is slightly above the industry median, while the Net Income margin is below the industry median due to the impact of extraordinary losses.

Growth and Capital Efficiency

The Revenue growth rate is substantially below the industry median, contrasting with the trend among peers, which are generally experiencing Revenue growth.

※Source: Compiled by the Company

Key Takeaways from the Results

1. Despite the decline in Revenue, the Operating Income margin improved by approximately 1.5pt YoY. Progress in improving core profitability through controls on costs and SG&A expenses is a key takeaway from the results.

2. Net Income declined 27.8% YoY due to the recognition of ¥3.49B in extraordinary losses, creating a divergence between assessments at the operating level and the bottom-line level. The extent to which the improving trend in Operating Income will be reflected in Net Income is the key focus going forward.

3. Achieving the full-year Operating Income forecast will require a margin in Q4 exceeding the cumulative margin to date. The operating status of construction in progress of ¥23.69B and profitability trends in Functional Materials will be observed as structural factors that could determine the full-year outcome.

Theoretical Share Price (Reference Value)

Sensitivity: ¥6,987–¥7,389 for a ±1% change in the Cost of Equity, and ¥7,167–¥7,194 for a ±0.1 change in ω.

Notes:

• Net Income is substantially compressed relative to Operating Income due to tax burdens, acquisition-related expenses, and non-controlling interests, among other factors (Net Income ÷ Operating Income: 47%). This value reflects that compression at face value; if the factors are temporary, underlying earning power may be higher.
• Because forecast ROE is below the Cost of Equity, the theoretical value is below Book Value Per Share.
• Net assets as of the end of the quarter are used; therefore, there is a timing difference relative to the full-year forecast.
• Because net assets include non-controlling interests, the theoretical value may be calculated somewhat higher.

(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest rate reference month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; it is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices.)

---

This report is an earnings analysis document automatically generated by AI based on XBRL earnings release data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by the Company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting a professional as necessary.

---End of Report---

---

AI Financial Analysis

Executive Summary

FY2026 Q3 results were operationally strong despite modest revenue contraction, but reported net income was reduced materially by exceptional charges. Revenue declined 0.9% YoY to ¥111.67bn. Operating income increased 18.7% YoY to ¥10.31bn, demonstrating substantial improvement in underlying profitability. Gross profit rose to ¥25.82bn from ¥23.61bn in the prior-year period. The gross margin expanded by 217bp YoY to 23.1%, reflecting a meaningful improvement in the cost-of-sales ratio. Operating margin expanded by 152bp YoY to 9.2%, from 7.7% a year earlier. This margin improvement is particularly positive given the slight sales decline. Ordinary income rose 9.3% YoY to ¥10.49bn, although it grew more slowly than operating income. Net income declined 27.8% YoY to ¥4.98bn and EPS was ¥380.51. The principal reason for the divergence was a ¥3.49bn extraordinary loss, against ¥0.23bn in the prior-year period. This included a ¥2.24bn impairment charge in the Functional Materials segment and was only partly offset by a ¥0.82bn gain on sales of investment securities. Consequently, the net margin fell to 4.5%, below the operating margin trend would otherwise indicate. Comprehensive income nevertheless increased to ¥8.58bn, supported by foreign currency translation adjustments. The balance sheet remains conservative, with a 225.5% current ratio, 172.4% quick ratio, and 15.3% debt-to-capital ratio. The company is also advancing a substantial investment program, as construction in progress reached ¥23.69bn, or 42.5% of PPE. Full-year operating income guidance of ¥15.0bn implies a 68.7% Q3 progress rate, moderately below the standard 75% seasonal benchmark but not a major deviation. The key issue into FY-end is whether cost and product-mix gains can be sustained while the company completes and monetizes its high level of construction in progress.

Profitability Analysis

The reported annualized DuPont ROE is 6.7%, decomposed into a 4.5% net profit margin, 0.989x annualized asset turnover, and 1.51x financial leverage. The largest positive operating change was margin expansion rather than revenue growth: gross margin improved 217bp YoY and operating margin improved 152bp YoY. Gross profit increased 9.4% YoY while SG&A increased 4.0% YoY to ¥15.51bn, indicating favorable operating leverage at the gross-profit level. However, SG&A grew faster than revenue, which declined 0.9%, so further sales recovery is important to preserve the improved operating margin. The core business is the Absorbent Resins segment, which generated ¥87.43bn in sales and ¥8.25bn in segment profit, accounting for about 80% of consolidated segment profit. Its segment margin improved to 9.4% from 7.3% in the prior-year period, and segment profit rose 28.3% despite sales declining 0.7%. Functional Materials generated ¥24.00bn in sales and ¥2.04bn in segment profit; sales declined 1.5% and segment profit declined 7.4%, with margin falling to 8.5% from 9.0%. Other businesses generated ¥0.23bn in external sales and ¥0.19bn in segment profit. The Absorbent Resins margin improvement was therefore the principal driver of consolidated earnings growth. The extended DuPont tax burden was 0.629, reflecting a 37.1% effective tax rate and reducing conversion of pre-tax earnings into net income. The reported interest burden of 0.768 is below the 0.80 warning threshold, indicating that the relationship between EBIT and pre-tax income was adversely affected during the period; however, cash interest expense was only ¥0.19bn and interest coverage remained very strong at 53.15x. The more material drag on shareholder returns was the exceptional-loss burden, not servicing capacity. The 6.7% annualized ROE remains below the 8% benchmark, principally because the exceptional charges compressed net margin.

Growth Assessment

Top-line growth remains soft, with Q3 cumulative revenue down 0.9% YoY. Underlying profit growth was considerably stronger than sales growth, as operating income rose 18.7% YoY and gross profit rose 9.4% YoY. This indicates that pricing, product mix, input costs, manufacturing efficiency, or a combination of these factors improved substantially. The Absorbent Resins segment provides the clearest evidence of improved earnings resilience, as its profit growth materially exceeded its modest sales decline. Functional Materials remains a weaker earnings contributor in the current period, with both sales and segment profit declining. The impairment of polyethylene powder manufacturing equipment at the Chiba plant points to a weaker expected return profile for part of the Functional Materials asset base. R&D expense increased 5.9% YoY to ¥2.10bn, but represented only 1.9% of revenue. This low R&D intensity may be consistent with mature chemical manufacturing operations, but it could constrain innovation capacity and product renewal if the company faces more technology-intensive competition. Full-year revenue guidance is ¥148.0bn, and Q3 progress is 75.5%, broadly in line with the normal 75% pace. Full-year operating and ordinary income guidance is ¥15.0bn each, with progress rates of 68.7% and 70.0%, respectively. This requires a stronger Q4 earnings contribution than the cumulative run rate, although the shortfall versus the standard progress benchmark is less than 10 percentage points. Full-year net income guidance of ¥7.0bn has a 71.2% progress rate, suggesting that management expects the exceptional losses recognized through Q3 not to recur at the same scale in Q4. Growth durability will depend on sustained Absorbent Resins profitability, a recovery in Functional Materials, and timely commissioning of projects under construction.

Financial Health

Liquidity is strong, with current assets of ¥85.65bn against current liabilities of ¥37.98bn, producing a current ratio of 225.5%. The quick ratio of 172.4% confirms that liquidity is not dependent on inventory liquidation. Cash and deposits totaled ¥19.55bn and covered short-term loans of ¥7.17bn by 2.73x. Working capital was a substantial ¥47.67bn. Total interest-bearing debt was ¥18.07bn, while total equity was ¥99.95bn and the reported debt-to-equity ratio was 0.51x, well below the 2.0x high-leverage warning threshold. Debt-to-capital was also conservative at 15.3%. Interest coverage of 53.15x indicates ample capacity to service interest obligations. Long-term loans increased by ¥5.90bn, or 118.0% YoY, to ¥10.90bn, while short-term loans decreased by ¥6.16bn, or 46.2%, to ¥7.17bn. This represents a favorable refinancing profile shift from short-term toward longer-term funding rather than an increase in aggregate funding stress. The short-term debt ratio of 39.7% is manageable given cash coverage and the high current ratio. PPE accounted for 37.0% of total assets and construction in progress alone totaled ¥23.69bn, indicating that capital deployment and project execution are now important balance-sheet considerations. No current-ratio or debt-to-equity warning is triggered.

Notable B/S Changes

Long-term loans: +¥5.90bn (+118.0%) to ¥10.90bn - financing has shifted toward longer maturities, improving maturity alignment during the investment phase. Short-term loans: -¥6.16bn (-46.2%) to ¥7.17bn - reduced short-term refinancing exposure and is well covered by ¥19.55bn of cash. Accounts receivable: +¥5.02bn (+16.0%) to ¥36.31bn - the absolute increase, together with 89 annualized receivable days, warrants scrutiny of collection efficiency and customer-credit exposure. Construction in progress: +¥2.63bn (+18.1%) to ¥23.69bn - now 42.5% of PPE, indicating a large investment pipeline with heightened completion, cost-control, and return-on-capital risk. Total PPE: +¥4.00bn (+7.7%) to ¥55.68bn - asset expansion is being led by projects not yet placed into service, increasing the importance of future utilization.

Cash Flow Quality

Dividend Sustainability

The Q2 dividend was ¥100 per share. The calculated payout ratio based on the paid interim dividend and Q3 cumulative net income was 28.1%, indicating a modest earnings commitment at this stage of the fiscal year. Full-year DPS guidance is ¥220, implying a ¥120 year-end dividend if the interim dividend remains ¥100. Based on full-year EPS guidance of ¥535.73, the implied full-year dividend payout ratio is approximately 41.1%. This is below the 60% sustainability benchmark and leaves a meaningful earnings retention buffer. The balance sheet is also supportive of shareholder distributions, given ¥19.55bn in cash, strong liquidity ratios, and low debt-to-capital. The principal constraint on distribution flexibility is the substantial capital-investment pipeline represented by ¥23.69bn of construction in progress. The current policy outlook appears sustainable provided that the projected FY2026 net income of ¥7.0bn is achieved and the investment program does not require materially higher funding.

Risk Assessment

Business risks include Demand and pricing risk: consolidated sales fell 0.9% YoY, and Functional Materials sales declined 1.5% YoY, leaving earnings recovery dependent on margin rather than volume growth., Functional Materials asset-utilization risk: the ¥2.24bn impairment of polyethylene powder production equipment at the Chiba plant indicates reduced recoverable value and raises the risk of weaker returns from this product area., Manufacturing working-capital risk: reported annualized receivable days of 89 exceed the 60-day warning threshold, tying up capital and increasing exposure to customer-collection delays., Inventory risk: reported annualized inventory days of 64 exceed the 60-day benchmark. With finished goods of ¥20.16bn, inventory remains exposed to demand changes, pricing pressure, and potential obsolescence., Chemical-manufacturing risk: profitability remains exposed to changes in feedstock, energy, logistics, and environmental-compliance costs, which can affect margins even if sales volumes are stable., Innovation risk: R&D intensity of 1.9% is below the 3% general manufacturing warning level. Although it may fit a mature materials portfolio, sustained low investment could weaken product differentiation and long-term pricing power..

Financial risks include Capital-project execution risk: construction in progress of ¥23.69bn equals 42.5% of PPE, well above the 20% alert level. Delays, cost overruns, or weak post-completion utilization could dilute returns and create further impairment exposure., Earnings-conversion risk: the reported 0.768 interest-burden metric is below the 0.80 warning threshold, indicating a material reduction from EBIT to pre-tax earnings in the current period. This should be monitored alongside non-operating and exceptional items, despite strong 53.15x cash interest coverage., Exceptional-item risk: extraordinary losses of ¥3.49bn, including the impairment charge, exceeded extraordinary income of ¥0.92bn and reduced reported net income materially., Foreign-exchange risk: foreign exchange losses of ¥0.34bn were recognized in non-operating expenses, while comprehensive income was supported by foreign currency translation adjustments; exchange-rate movements can therefore affect both earnings and equity..

Key concerns include Highest priority is execution and return realization on the unusually large construction-in-progress balance., Second priority is working-capital discipline, particularly collection efficiency at 89 annualized receivable days and inventory control at 64 annualized inventory days., Third priority is whether the strong Absorbent Resins margin improvement can offset continued weakness and impairment risk in Functional Materials., The impairment charge demonstrates that accounting earnings can remain volatile even when operating profit is improving..

Investment Implications

Key takeaways include Operating performance improved materially: operating income increased 18.7% YoY and operating margin expanded 152bp to 9.2%., Absorbent Resins is the core earnings engine, contributing ¥8.25bn of ¥10.31bn consolidated segment profit and improving its segment margin to 9.4%., Reported net income understates operating momentum because of a ¥2.24bn impairment and a ¥3.49bn total extraordinary-loss charge., Liquidity, leverage, and interest-servicing capacity are strong, supporting resilience through the ongoing investment phase., Capital efficiency remains the main medium-term issue, given annualized ROE of 6.7%, elevated receivable and inventory days, and the large construction-in-progress balance..

Metrics to watch include Absorbent Resins sales growth and segment margin versus the Q3 level of 9.4%., Functional Materials profitability and any additional impairment indicators following the Chiba plant charge., Completion timing, spending discipline, and utilization of ¥23.69bn of construction in progress., Annualized receivable days, currently 89 days, and annualized inventory days, currently 64 days., Q4 operating income required to close the gap from the 68.7% Q3 progress rate to ¥15.0bn full-year guidance., R&D intensity, currently 1.9%, as an indicator of longer-term portfolio renewal..

Regarding relative positioning, The company combines good operating-margin performance and a conservative balance sheet with below-benchmark annualized ROE and elevated capital-cycle execution requirements. Relative to a typical manufacturing quality profile, liquidity and leverage are strengths, while receivables, inventory efficiency, low R&D intensity, and the unusually high construction-in-progress ratio require closer monitoring.